Notably, recipients of Gata2/Asxl1 double haploinsufficient HSCs exhibited lower PB engraftment than recipients of either Asxl1 +/fl ; Vav-iCre + or Gata2 +/fl ; Vav-iCre + HSCs starting from week 8, though this reduction did not reach statistical significance compared to recipients receiving Gata2 +/fl ; Vav-iCre + HSCs ( Figure S4 A).
← all excerpts
Impaired DNA damage responses and inflammatory signaling underpin hematopoietic stem cell defects in Gata2 haploinsufficiency.
1
—
—